Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Meet the Stars of the Feline World: Well known Pet Feline Varieties - 2Vote in favor of your Favored sort of footwear
- 3The Solution to Ecological Protection: Saving Nature for People in the future
- 4Woman gives birth on roadside after hospital allegedly sent her home: Family
- 5A Manual for Pick Viable Psychological well-being Backing Administrations In 2024
- I’m a doctor. Here are 10 science-backed tips to help you get healthier.
- The Most Compelling Books of the 10 years
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Manual for Individual accounting Rudiments for Fledglings
- Forum Dvorah demands clear support for women in combat as IDF gender debate escalates
- Gulf countries roll out more autonomous taxis
- EU Council president: Ukraine should receive binding guarantees
- Philippines evacuates 3,000 villagers after volcano activity raises alert level
